Form 4: INSMED CEO William Lewis Executes Stock Options and Sells Shares Under Pre-Arranged Plan

INSMED Inc.'s Chair and CEO, William Lewis, acquired 6,830 shares through option exercise and subsequently sold 6,830 shares at prices ranging from $101.10 to $103.37, all pursuant to a Rule 10b5-1 trading plan.

Summary

• William Lewis, Chair and CEO of INSMED Inc., executed a transaction on July 15, 2025, under a Rule 10b5-1 trading plan adopted on September 12, 2024.
• Acquired 6,830 shares of Common Stock by exercising stock options at a price of $10.85 per share.
• Simultaneously, sold a total of 6,830 shares of Common Stock in multiple transactions.
• Sales occurred at weighted average prices of $101.71 (2,168 shares), $102.66 (4,492 shares), and $103.32 (170 shares).
• Following these transactions, William Lewis directly holds 303,911 shares of Common Stock.
• Indirect beneficial ownership includes 233,924 shares and 13,695 stock options held by the Katie Procter Dynasty Trust, and 50,500 shares held by the William Lewis Family Legacy Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there is insider selling, it is part of a pre-planned 10b5-1 program, which mitigates concerns about opportunistic selling. The exercise of options at a low strike price and subsequent sale at a high market price indicates a profitable, planned transaction for the executive, not necessarily a negative signal for the company's future.

Positives

• The exercise of stock options at a significantly lower price ($10.85) compared to the sale prices (over $100) indicates a profitable transaction for the insider.
• Transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests the sales were not based on new, non-public information.

Negatives

• The sale of 6,830 shares by a key executive, even under a 10b5-1 plan, represents a reduction in their direct or indirect equity exposure to the company.

Future Outlook

NA

Industry Context

This filing is specific to an insider's personal trading activity and does not directly reflect broader industry trends. It is a routine disclosure for public company executives.

Related Party Transactions

• William Lewis's indirect beneficial ownership includes shares and stock options held by the Katie Procter Dynasty Trust and shares held by the William Lewis Family Legacy Trust, which are considered related party holdings.

Stakeholder Impact

• Shareholders may view the sale of shares by a key executive as a slight negative, but the execution under a Rule 10b5-1 plan typically reduces concerns about the executive's confidence in the company's future. The transaction itself does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

INSMED Inc., INSM, William Lewis, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, CEO, Director, Equity Transaction